Fractyl Health, Inc.
GUTS
$1.50
-$0.13-7.98%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -57.14% | -61.11% | -40.28% | 560.00% | 40.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -57.14% | -61.11% | -40.28% | 560.00% | 40.00% |
| Cost of Revenue | -100.00% | -72.00% | -48.94% | 533.33% | -33.33% |
| Gross Profit | -40.00% | -36.36% | -24.00% | 600.00% | 150.00% |
| SG&A Expenses | 74.89% | 6.55% | 126.24% | 158.41% | 2.17% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 94.13% | 71.17% | 92.75% | 78.13% | 7.23% |
| Operating Income | -94.21% | -71.51% | -93.56% | -77.93% | -7.22% |
| Income Before Tax | -30.19% | -47.16% | 43.01% | 72.16% | -60.74% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -30.19% | -47.16% | 43.01% | 72.16% | -60.74% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -30.19% | -47.16% | 43.01% | 72.16% | -60.74% |
| EBIT | -94.21% | -71.51% | -93.56% | -77.93% | -7.22% |
| EBITDA | -93.05% | -71.04% | -93.28% | -79.16% | -7.62% |
| EPS Basic | 95.39% | 94.97% | 97.84% | 97.84% | -42.16% |
| Normalized Basic EPS | 94.26% | 93.90% | 93.82% | 94.08% | -51.92% |
| EPS Diluted | 95.39% | 94.97% | 97.84% | 97.84% | -42.16% |
| Normalized Diluted EPS | 94.26% | 93.90% | 93.82% | 94.08% | -51.92% |
| Average Basic Shares Outstanding | 2,204.32% | 2,195.52% | 2,206.18% | 1,346.70% | 2.29% |
| Average Diluted Shares Outstanding | 2,204.32% | 2,195.52% | 2,206.18% | 1,346.70% | 2.29% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |